Comparison of Blood Cells Parameters and Complete Blood Count in Diabetic Patients: A Cross-sectional Study
Journal of Advances in Medical and Pharmaceutical Sciences, Volume 24, Issue 10,
Background and Aim: Diabetes is a type of metabolic disorder characterized by increased blood glucose, which is due to insulin resistance, insulin deficiency, or both. Changes in blood cell parameters in diabetes are controversial. The present study aimed to assess the blood cell parameters in diabetic patients compared to healthy individuals.
Methods: This cross-sectional study was performed on 540 cases (270 diabetic patients and 270 healthy individuals) over 20 years old who were referred to the clinics affiliated to Semnan University of Medical Sciences, Semnan, Iran, in 2018. The complete blood count (CBC) parameters were assessed in both groups, and demographic information was also collected via questionnaires. All the analyses were performed in SPSS software (version 22).
Results: In terms of gender, the majority of participants (61.2%) were female. The white blood cell (WBC) count in diabetic patients was significantly higher than that in the control group (P<0.001), and the hemoglobin (HGB) level was significantly lower in diabetic patients (P=0.009). There was no significant difference in the level of other indices between diabetic and control groups. There was a significant difference between the gender of diabetic patients in HGB, red blood cell (RBC) count, and platelets (PLT) (P<0.001). Moreover, HBG and RBC were less in patients with longer diabetes duration (P<0.001).
Conclusion: The obtained results pointed to a statistically significant difference in some hematological parameters of diabetic patients compared to non-diabetic individuals. More studies are needed to clarify the causal relationship between diabetes and these indices.
- Blood cells parameters
- Red Blood Cell (RBC)
- White Blood Cell (WBC)
How to Cite
Topaloğlu US, Göl MF, Sirakaya E, Tanriverdİ F. A window of opportunity against diabetes: frequency of microvascular and macrovascular complications in prediabetes. Eur Res J. 2022.
Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31-55.
Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2020;44(1):258-79.
Foster SR, Dilworth LL, Thompson RK, Alexander-Lindo RL, Omoruyi FO. Effects of combined inositol hexakisphosphate and inositol supplement on antioxidant activity and metabolic enzymes in the liver of streptozotocin-induced type 2 diabetic rats. Chem Biol Interact. 2017;275:108-15.
Luc K, Schramm-Luc A, Guzik TJ, Mikolajczyk TP. Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol. 2019;70(6):111-13.
Malik A, Morya RK, Saha S, Singh PK, Bhadada SK, Rana SV. Oxidative stress and inflammatory markers in type 2 diabetic patients. Eur J Clin Investig. 2020;50(6):e13238.
Demirtas L, Degirmenci H, Akbas EM, Ozcicek A, Timuroglu A, Gurel A, et al. Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes. Int J Clin Exp Med. 2015;8(7):11420-7.
Atlı H, Onalan E, Yakar B, Duzenci D, Dönder E. Predictive value of inflammatory and hematological data in diabetic and non-diabetic retinopathy. Eur Rev Med Pharmacol Sci. 2022;26(1):76-83.
Walinjkar RS, Khadse S, Kumar S, Bawankule S, Acharya S. Platelet indices as a predictor of microvascular complications in type 2 diabetes. Indian J Endocrinol Metab. 2019;23(2):206-10.
Liccardo D, Cannavo A, Spagnuolo G, Ferrara N, Cittadini A, Rengo C, et al. Periodontal disease: a risk factor for diabetes and cardiovascular disease. Int J Mol Sci. 2019;20(6):1414.
Beulens J, Rutters F, Rydén L, Schnell O, Mellbin L, Hart HE, et al. Risk and management of pre-diabetes. Eur J Prev Cardiol. 2019;26(2_suppl):47-54.
Gu Y, Hu K, Huang Y, Zhang Q, Liu L, Meng G, et al. White blood cells count as an indicator to identify whether obesity leads to increased risk of type 2 diabetes. Diabetes Res Clin Pract. 2018;141:140-7.
Adane T, Getaneh Z, Asrie F. Red blood cell parameters and their correlation with renal function tests among diabetes mellitus patients: a comparative cross-sectional study. Diabetes Metab Syndr Obes. 2020;13:3937-46.
MN, DJ, DK. Study of relationship between WBC count and diabetic complications. Int J Adv Med. 2017;4(4):1128-32.
Biadgo B, Melku M, Abebe SM, Abebe M. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. Diabetes Metab Syndr Obes. 2016;9:91-9.
Onalan E, Gozel N, Donder E. Can hematological parameters in type 2 diabetes predict microvascular complication development? Pak J Med Sci. 2019;35(6):1511-5.
Milosevic D, Panin VL. Relationship between hematological parameters and glycemic control in type 2 diabetes mellitus patients. J Med Biochem. 2019;38(2): 164-71.
Twig G, Afek A, Shamiss A, Derazne E, Tzur D, Gordon B, et al. White blood cells count and incidence of type 2 diabetes in young men. Diabetes Care. 2013;36(2): 276-82.
Uribe-Querol E, Rosales C. Neutrophils actively contribute to obesity-associated inflammation and pathological complications. Cells. 2022;11(12):1883.
Cohen E, Margalit I, Shochat T, Goldberg E, Krause I. Markers of chronic inflammation in overweight and obese individuals and the role of gender: a cross-sectional study of a large cohort. J Inflam Res. 2021;14:567-73.
Chen DL, Liess C, Poljak A, Xu A, Zhang J, Thoma C, et al. Phenotypic characterization of insulin-resistant and insulin-sensitive obesity. J Clin Endocrinol Metab. 2015;100(11):4082-91.
Eun Y, Han KD, Kim DH, Kim IY, Park EJ, Lee S, et al. Association between anemia and hyperuricemia: results from the Korean National Health and Nutrition Examination Survey. Sci Rep. 2019;9(1):19067.
Yang W, Cai X, Wu H, Ji L. Associations between metformin use and vitamin B12 levels, anemia, and neuropathy in patients with diabetes: a meta-analysis. J Diabetes. 2019;11(9):729-43.
Alam J, et al. A comparative analysis of biochemical and hematological parameters in diabetic and nondiabetic adults. Adv Med Sci. 2015;2(1):1-9.
Bekele BB, Negash S, Bogale B, Tesfaye M, Getachew D, Weldekidan F, et al. Effect of diabetes self-management education (DSME) on glycated hemoglobin (HbA1c) level among patients with T2DM: systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr. 2021;15(1):177-85.
Mushlih M. Difference of red blood cell count (RBC) levels in diabetes mellitus Type II with ulcers and without ulcers. J Riset Biologi Aplikasinya. 2020;2(1): 6-10.
Kachekouche Y, Dali-Sahi M, Benmansour D, Dennouni-Medjati N. Hematological profile associated with type 2 diabetes mellitus. Diabetes Metab Syndr. 2018;12(3):309-12.
Ziaee A, Ghorbani A, Kalbasi S, Hejrati A, Moradi S. Association of hematological indices with prediabetes: A cross-sectional study. Electron Physician. 2017;9(9):5206-11.
S. AlSalhi M, Devanesan S, E. AlZahrani K, AlShebly M, Al-Qahtani F, Farhat K et al. Impact of diabetes mellitus on human erythrocytes: atomic force microscopy and spectral investigations. Int J Environ Res Public Health. 2018;15(11):2368.
Su D, Guo Q, Gao Y, Han J, Yan B, Peng L, et al. The relationship between red blood cell distribution width and blood pressure abnormal dipping in patients with essential hypertension: a cross-sectional study. BMJ Open. 2016;6(2):e010456.
Knapp M, Tu X, Wu R. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol Sin. 2019;40(1):1-8.
King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol. 2004;122(4):333-8.
Anand S, Krishnan N, Jukić M, Križanac Z, Llorente Muñoz CM, Pogorelić Z. Utility of red cell distribution width (RDW) as a noninvasive biomarker for the diagnosis of acute appendicitis: A systematic review and meta-analysis of 5222 cases. Diagnostics (Basel). 2022;12(4):1011.
Kodiatte TA, Manikyam UK, Rao SB, Jagadish TM, Reddy M, Lingaiah HK, et al. Mean platelet volume in type 2 diabetes mellitus. J Lab Physicians. 2012;4(1):5-9.
Buch A, Kaur S, Nair R, Jain A. Platelet volume indices as predictive biomarkers for diabetic complications in Type 2 diabetic patients. J Lab Physicians. 2017;9(2):84-8.
Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z, Zhao Y. From pre-diabetes to diabetes: diagnosis, treatments and translational research. Medicina (Kaunas). 2019;55(9):546.
Gyawali P, Martin SA, Heilbronn LK, Vincent AD, Taylor AW, Adams RJT, et al. The role of sex hormone-binding globulin (SHBG), testosterone, and other sex steroids, on the development of type 2 diabetes in a cohort of community-dwelling middle-aged to elderly men. Acta Diabetol. 2018;55(8):861-72.
Wittert G, Bracken K, Robledo KP, Grossmann M, Yeap BB, Handelsman DJ, et al. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol. 2021;9(1):32-45.
Shim WS, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, et al. The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract. 2006;73(3):284-91.
Harusato I, Fukui M, Tanaka M, Shiraishi E, Senmaru T, Sakabe K, et al. Hemoglobin concentration in men with type 2 diabetes mellitus. Metabolism. 2010;59(6):808-13.
Chung GE, Yim JY, Kim D, Kwak MS, Yang JI, Chung SJ, et al. Associations between hemoglobin concentrations and the development of incidental metabolic syndrome or nonalcoholic fatty liver disease. Dig Liver Dis. 2017;49(1):57-62.
Ito K, Yokota S, Watanabe M, Inoue Y, Takahashi K, Himuro N, et al. Anemia in diabetic patients reflects severe tubulointerstitial injury and aids in clinically predicting a diagnosis of diabetic nephropathy. Intern Med. 2021;60(9): 1349-57.
Abstract View: 127 times
PDF Download: 52 times